Isolation, Invitro, Invivo Anti-inflammatory, Analgesic and Antioxidant Potential of Habenaria Plantegania Lindl

Overview

Journal Inflammopharmacology

Specialty Pharmacology

Date 2024 Feb 9

PMID 38334860

Authors

Osama M Alshehri

Madeeha Shabnam

Saeed Ahmed Asiri

Mater H Mahnashi

Abdul Sadiq

Muhammad Saeed Jan

Affiliations

Soon will be listed here.

Abstract

Habenaira plantaginea belong to orchid family which is native to Asia. Members of this family are commonly famous for the cure of pain and inflammation. To date, no research was found on isolation of compounds from this plant for the treatment of inflammation and analgesia nor has been published to our knowledge. The purpose of this study was to evaluate an analgesic, anti-inflammatory and anti-oxidant activity of the isolated compound from the most potent chloroform sub-fraction and the isolated compounds form the habenaria plantaginea. Anti-inflammatory analgesic and antioxidant potential of the various chloroform sub-fractions and isolated compounds from the most potent sub-fraction (HP-1 & HP-1) were screened for their in vitro enzymatic assays. Furthermore, prior to in-vivo investigation, the isolated compounds were subjected for their toxicity study. The potent compound was then examined for acetic acid-induced writhing, hot plate test, carrageenan-induced inflammation assays. Further various phlogistic agents were used for the evaluation of mechanism. In the COX-2 inhibitory assay the chloroform sub fraction Cf-4 demonstrated excellent activity as compared to the other sub-fraction with 92.15% inhibition. The COX-2 enzyme make prostaglandins which are directly involved in inflammation. Likewise against 5-LOX the Cf-4 was the most potent sub-fraction with IC 3.77 µg/mL. The 5-LOX catalyzes the biosynthesis of leukotrienes which is a group of lipid mediators of inflammation derived from arachidonic acid. Free radicals can induce inflammation through cellular damage while chronic inflammation generates a large number of free radicals, whose eventually lead to inflammation. In antioxidant assays the Cf-4 fraction was displayed excellent results against ABTS, DPPH and HO free radical with 88.88, 77.44, and 65.52% inhibition at highest concentration. Likewise, the compound HP-1 demonstrated 88.81, 89.34 and 80.43% inhibition while compound HP-2 displayed 84.34, 91.52 and 82.34% inhibition against ABTS, DPPH and HO free radical which were comparable to the standard drug ascorbic acid respectively. This study's findings validate the use of this species as traditional use.

Citing Articles

In vitro 5-LOX inhibitory and antioxidant potential of isoxazole derivatives.

Alam W, Khan H, Jan M, Darwish H, Daglia M, Elhenawy A PLoS One. 2024; 19(10):e0297398.

PMID: 39365759 PMC: 11452043. DOI: 10.1371/journal.pone.0297398.

Evaluation of Reichb. for antioxidant, anti-inflammatory, and antinociceptive effects with and approaches.

Ahmed Asiri S, Shabnam M, Zafar R, Alshehri O, Alshehri M, Sadiq A Front Chem. 2024; 12:1351827.

PMID: 38566899 PMC: 10985259. DOI: 10.3389/fchem.2024.1351827.

References

Ahmad S, Khan S, Zeb A, Ali Shah S, Ahmad B, Khan A . Evaluation of analgesic, antiamnesic and antidiarrheal potentials of extract using animal model. Saudi J Biol Sci. 2021; 28(11):6352-6358. PMC: 8568719. DOI: 10.1016/j.sjbs.2021.06.095. View

Alam F, Hanif M, Rahman A, Ali S, Jan S . In vitro, in vivo and in silico evaluation of analgesic, anti-inflammatory, and anti-pyretic activity of salicylate rich fraction from Gaultheria trichophylla Royle (Ericaceae). J Ethnopharmacol. 2022; 301:115828. DOI: 10.1016/j.jep.2022.115828. View

Alqahtani Y . Bioactive stigmastadienone from Isodon rugosus as potential anticholinesterase, α-glucosidase and COX/LOX inhibitor: In-vitro and molecular docking studies. Steroids. 2021; 172:108857. DOI: 10.1016/j.steroids.2021.108857. View

Sadiq A, Mahnashi M, Alyami B, Alqahtani Y, Alqarni A, Rashid U . Tailoring the substitution pattern of Pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition. Bioorg Chem. 2021; 112:104969. DOI: 10.1016/j.bioorg.2021.104969. View

Huneif M, Mahnashi M, Jan M, Shah M, Almedhesh S, Alqahtani S . New Succinimide-Thiazolidinedione Hybrids as Multitarget Antidiabetic Agents: Design, Synthesis, Bioevaluation, and Molecular Modelling Studies. Molecules. 2023; 28(3). PMC: 9918900. DOI: 10.3390/molecules28031207. View

Finch S, Boundy M, Harwood D . The Acute Toxicity of Tetrodotoxin and Tetrodotoxin⁻Saxitoxin Mixtures to Mice by Various Routes of Administration. Toxins (Basel). 2018; 10(11). PMC: 6266834. DOI: 10.3390/toxins10110423. View

Genovese M, Nesi I, Caselli A, Paoli P . Natural α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors: A Source of Scaffold Molecules for Synthesis of New Multitarget Antidiabetic Drugs. Molecules. 2021; 26(16). PMC: 8400511. DOI: 10.3390/molecules26164818. View

Hussain F, Khan Z, Jan M, Ahmad S, Ahmad A, Rashid U . Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives. Bioorg Chem. 2019; 91:103128. DOI: 10.1016/j.bioorg.2019.103128. View

Jan M, Ahmad S, Hussain F, Ahmad A, Mahmood F, Rashid U . Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents. Eur J Med Chem. 2019; 186:111863. DOI: 10.1016/j.ejmech.2019.111863. View

10.

Javed M, Ashraf N, Jan M, Mahnashi M, Alqahtani Y, Alyami B . Structural Modification, , , , and Exploration of Pyrimidine and Pyrrolidine Cores for Targeting Enzymes Associated with Neuroinflammation and Cholinergic Deficit in Alzheimer's Disease. ACS Chem Neurosci. 2021; 12(21):4123-4143. DOI: 10.1021/acschemneuro.1c00507. View

11.

Javed M, Bibi S, Jan M, Ikram M, Zaidi A, Farooq U . Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies. RSC Adv. 2022; 12(35):22503-22517. PMC: 9366597. DOI: 10.1039/d2ra04183a. View

12.

Javed M, Jan M, Shbeer A, Al-Ghorbani M, Rauf A, Wilairatana P . Evaluation of pyrimidine/pyrrolidine-sertraline based hybrids as multitarget anti-Alzheimer agents: In-vitro, in-vivo, and computational studies. Biomed Pharmacother. 2023; 159:114239. DOI: 10.1016/j.biopha.2023.114239. View

13.

Khan J, Ali G, Rashid U, Khan R, Jan M, Ullah R . Mechanistic evaluation of a novel cyclohexenone derivative's functionality against nociception and inflammation: An in-vitro, in-vivo and in-silico approach. Eur J Pharmacol. 2021; 902:174091. DOI: 10.1016/j.ejphar.2021.174091. View

14.

Khan A, Pervaiz A, Ansari B, Ullah R, Shah S, Khan H . Phytochemical Profiling, Anti-Inflammatory, Anti-Oxidant and In-Silico Approach of Bioss (Bark). Molecules. 2022; 27(13). PMC: 9268425. DOI: 10.3390/molecules27134081. View

15.

Mahmood F, Khan J, Mahnashi M, Jan M, Javed M, Rashid U . Anti-Inflammatory, Analgesic and Antioxidant Potential of New (2,3)-2-(4-isopropylbenzyl)-2-methyl-4-nitro-3-phenylbutanals and Their Corresponding Carboxylic Acids through In Vitro, In Silico and In Vivo Studies. Molecules. 2022; 27(13). PMC: 9268591. DOI: 10.3390/molecules27134068. View

16.

Mahnashi M, Alshahrani M, Nahari M, Hassan S, Jan M, Ayaz M . In-Vitro, In-Vivo, Molecular Docking and ADMET Studies of 2-Substituted 3,7-Dihydroxy-4H-chromen-4-one for Oxidative Stress, Inflammation and Alzheimer's Disease. Metabolites. 2022; 12(11). PMC: 9694897. DOI: 10.3390/metabo12111055. View

17.

Alshehri O, Zeb A, Shah S, Mahnashi M, Ahmed Asiri S, Alqahtani O . Investigation of anti-nociceptive, anti-inflammatory potential and ADMET studies of pure compounds isolated from Wall. ex Benth. Front Pharmacol. 2024; 15:1328128. PMC: 10897015. DOI: 10.3389/fphar.2024.1328128. View

18.

Mansouri M, Hemmati A, Naghizadeh B, Mard S, Rezaie A, Ghorbanzadeh B . A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats. Indian J Pharmacol. 2015; 47(3):292-8. PMC: 4450555. DOI: 10.4103/0253-7613.157127. View

19.

Mense S . Algesic agents exciting muscle nociceptors. Exp Brain Res. 2009; 196(1):89-100. DOI: 10.1007/s00221-008-1674-4. View

20.

Mohammadifard F, Alimohammadi S . Chemical Composition and Role of Opioidergic System in Antinociceptive Effect of Essential Oil. Basic Clin Neurosci. 2019; 9(5):357-366. PMC: 6360493. DOI: 10.32598/bcn.9.5.357. View